Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
CNY 252.97
(0.34%)
CNY 252.97
(0.34%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 14.14 Billion CNY | 11.09% |
| 2022 | 11.94 Billion CNY | 21.69% |
| 2021 | 9.82 Billion CNY | 20.65% |
| 2020 | 7.99 Billion CNY | 37.52% |
| 2019 | 5.85 Billion CNY | 26.36% |
| 2018 | 4.7 Billion CNY | 36.03% |
| 2017 | 3.26 Billion CNY | 49.13% |
| 2016 | 2.12 Billion CNY | 28.23% |
| 2015 | 1.44 Billion CNY | 54.16% |
| 2014 | 1.12 Billion CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 4.89 Billion CNY | 49.76% |
| 2024 Q1 | 3.54 Billion CNY | 69.51% |
| 2024 Q3 | 3.52 Billion CNY | -33.96% |
| 2023 Q2 | 4.46 Billion CNY | 49.92% |
| 2023 Q4 | 1.61 Billion CNY | -58.3% |
| 2023 Q3 | 3.86 Billion CNY | -13.57% |
| 2023 FY | - CNY | 11.09% |
| 2023 Q1 | 2.98 Billion CNY | 67.67% |
| 2022 Q2 | 3.63 Billion CNY | 49.51% |
| 2022 FY | - CNY | 21.69% |
| 2022 Q4 | 1.77 Billion CNY | -45.15% |
| 2022 Q3 | 3.24 Billion CNY | -10.88% |
| 2022 Q1 | 2.43 Billion CNY | 67.57% |
| 2021 FY | - CNY | 20.65% |
| 2021 Q4 | 1.45 Billion CNY | -46.24% |
| 2021 Q3 | 2.7 Billion CNY | -11.47% |
| 2021 Q2 | 3.05 Billion CNY | 57.56% |
| 2021 Q1 | 1.93 Billion CNY | 30.66% |
| 2020 Q4 | 1.48 Billion CNY | -33.94% |
| 2020 Q3 | 2.24 Billion CNY | -9.52% |
| 2020 Q2 | 2.47 Billion CNY | 67.63% |
| 2020 FY | - CNY | 37.52% |
| 2020 Q1 | 1.47 Billion CNY | -6.25% |
| 2019 Q1 | 1.3 Billion CNY | 22.11% |
| 2019 FY | - CNY | 26.36% |
| 2019 Q4 | 1.57 Billion CNY | 21.64% |
| 2019 Q3 | 1.29 Billion CNY | -11.37% |
| 2019 Q2 | 1.46 Billion CNY | 12.04% |
| 2018 Q3 | 1.17 Billion CNY | -79.31% |
| 2018 Q1 | 1.11 Billion CNY | 64.39% |
| 2018 FY | - CNY | 36.03% |
| 2018 Q4 | 1.06 Billion CNY | -8.83% |
| 2018 Q2 | 5.66 Billion CNY | 408.82% |
| 2017 FY | - CNY | 49.13% |
| 2017 Q4 | 677.84 Million CNY | -28.45% |
| 2017 Q3 | 947.41 Million CNY | 0.0% |
| 2016 FY | - CNY | 28.23% |
| 2015 FY | - CNY | 54.16% |
| 2014 FY | - CNY | 0.0% |